title: [Distribution and acute toxicity of a new morpholinoanthracycline, MX2, in normal rat brain after intra-arterial injection].
abstract: Intra-arterial infusion chemotherapy has been applied for the treatment of malignant brain tumors to increase the distribution of the drug into the tumor. MX2, a new morpholinoanthracycline, is a lipophilic compound, and has a strong antineoplastic effect against human and rat glioma cells. In this report, the acute toxicity and distribution of MX2 after intracarotid injection were studied using female Wistar rats weighing 150 g. To test the acute toxicity, various doses ranging 1.5 to 6 mg/kg was administered. All rats died within 4 days when received more than 3 mg/kg of intra-arterial or intravenous MX2. No rats died if the dose was reduced to less than 2 mg/kg. For the purpose to examine distribution in the brain, rats which received 2 mg/kg of intra-carotid MX2 were killed 5 to 120 min. after injection. The level of MX2 in the ipsilateral brain tissue reached to the maximum 5 min. after injection, and then rapidly decreased. The maximum concentration of MX2 in the ipsilateral brain was 25-fold higher than that in the contralateral brain, and 20-fold higher than that after intravenous injection of the same dose. The AUC (area under the curve) in the ipsilateral brain after intra-carotid injection was 8.0-fold higher than that in the contralateral brain, and 7.3-fold higher than that after intravenous injection of the same dose. These results indicate that intra-carotid administration can increase the distribution of MX2 in the normal brain.
authors.affiliation: Dept. of Neurosurgery, Osaka University Medical School, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Izumoto
authors.forename: N
authors.initials: N
authors.lastname: Arita
authors.forename: T
authors.initials: T
authors.lastname: Hayakawa
authors.forename: T
authors.initials: T
authors.lastname: Ohnishi
authors.forename: S
authors.initials: S
authors.lastname: Hiraga
authors.forename: T
authors.initials: T
authors.lastname: Taki
authors.forename: H
authors.initials: H
authors.lastname: Yamamoto
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000493:pharmacokinetics* / Q000633:toxicity; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002360:Carubicin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000633:toxicity; D005260:Female; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D000903:Antibiotics, Antineoplastic; C053537:morpholinoanthracycline MX2; D002360:Carubicin